Harvard Bioscience Inc (HBIO)

Currency in USD
0.529
+0.040(+8.17%)
Closed·
0.5290.000(0.00%)
·

HBIO Earnings

Latest Release
Aug 11, 2025
EPS / Forecast
-0.01 / -0.005
Revenue / Forecast
20.45M / 21.40M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/0.015--/21.5M----Free Sign Up
06/2025-0.01/-0.00520.45M/21.4M-100%-4.44%Free Sign Up
03/2025-0.01/-0.0121.77M/20M0%+8.85%Free Sign Up
12/20240.06/0.0524.6M/24.15M+20%+1.86%Free Sign Up
09/2024-0.02/0.0221.97M/23.7M-200%-7.3%Free Sign Up
06/2024--/0.0523.1M/26.4M-100%-12.5%Free Sign Up
03/20240.02/0.0524.5M/28M-60%-12.5%Free Sign Up
12/20230.04/0.0528.2M/29.1M-20%-3.09%Free Sign Up
09/20230.01/0.0425.4M/28.02M-75%-9.35%Free Sign Up
06/20230.04/0.0628.8M/29.63M-33.33%-2.8%Free Sign Up

All numbers in USD

Harvard Bioscience Inc Earnings Call Summary for Q2/2025

  • Q2 revenue of $20.5M missed forecast; EPS at -$0.01 below expectations. Net debt reduced to $27.9M. Stock resilient despite mixed results.
  • Adjusted EBITDA improved to $1.5M from $1.3M YoY. Gross margin slightly down at 56.4%. Operating cash flow at $2.8M.
  • Q3 revenue guidance: $19-$21M. Gross margin guidance: 56-58%. Company optimistic about NIH funding and academic purchasing in 2026.
  • New product launches, including SOHO telemetry platform and MeSH MEA organoid platform expansion, expected to drive future growth.
  • CEO emphasized focus on debt restructuring and balance sheet investment. Expressed confidence in overcoming market uncertainties.
Last Updated: 11/08/2025, 13:50
Read Full Transcript

FAQ

What Is Harvard Bioscience's Earnings Per Share (TTM)?

The Harvard Bioscience EPS (TTM) is -1.31.

When Is The Next Harvard Bioscience Earnings Date?

Harvard Bioscience will release its next earnings report on 05 Nov 2025.

What Is Harvard Bioscience’s Revenue Forecasts For Upcoming Quarters?

Harvard Bioscience’s revenue forecast is 21.50M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.